RecruitingNot ApplicableNCT05934994

Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions

Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions Whose Malignant Origin Cannot be Excluded on Conventional Imaging


Sponsor

Central Hospital, Nancy, France

Enrollment

68 participants

Start Date

Sep 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The hypothesis of the study is that non-invasive Single photon emission computed tomography (SPECT-CT) bone scintigraphy makes it possible to better characterize solitary bone lesions, in particular the exclusion of their malignancy in order to avoid unnecessary biopsy and possible complications for the patient.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria5

  • Person, having received complete information on the organization of the research and having signed the informed consent and:
  • Age ≥ 18 years old.
  • Having read and understood the information document.
  • Affiliated to a social security scheme.
  • Patient with an indeterminate solitary bone lesion on conventional imaging, for which an indication for biopsy +/- excision is planned.

Exclusion Criteria5

  • Pregnant woman or woman of childbearing age and without contraceptive means or nursing mother.
  • Unstable medical condition and/or inability to remain still during recordings.
  • Known allergy to one of the components of the radiopharmaceutical technetium-99m-Technescan HDP (product required to perform the bone scan).
  • Person referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code.
  • Persons deprived of their liberty by a judicial or administrative decision, persons subject to psychiatric care under articles L. 3212-1, L. 3213-1

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBone scan

the bone scintigraphy will include 3 stages: study of perfusion then early tissue uptake and finally late bone fixation


Locations(1)

CHRU Nancy

Vandœuvre-lès-Nancy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05934994


Related Trials